Stan Berenshteyn
Stock Analyst at Wells Fargo
(2.12)
# 2,815
Out of 4,931 analysts
63
Total ratings
50%
Success rate
-8.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMWL American Well | Maintains: Overweight | $15 → $12 | $7.67 | +56.45% | 4 | Aug 7, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $55 → $62 | $58.58 | +5.84% | 11 | Aug 4, 2025 | |
| OMCL Omnicell | Maintains: Overweight | $37 → $40 | $30.98 | +29.12% | 17 | Jul 21, 2025 | |
| VEEV Veeva Systems | Maintains: Overweight | $285 → $300 | $281.66 | +6.51% | 6 | May 29, 2025 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $10 → $8 | $6.96 | +15.03% | 3 | May 8, 2025 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $7 | $3.62 | +93.64% | 8 | Apr 29, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $110 → $125 | $91.05 | +37.29% | 9 | Feb 26, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $13 → $10 | $3.74 | +167.38% | 5 | Jan 21, 2025 |
American Well
Aug 7, 2025
Maintains: Overweight
Price Target: $15 → $12
Current: $7.67
Upside: +56.45%
Doximity
Aug 4, 2025
Maintains: Equal-Weight
Price Target: $55 → $62
Current: $58.58
Upside: +5.84%
Omnicell
Jul 21, 2025
Maintains: Overweight
Price Target: $37 → $40
Current: $30.98
Upside: +29.12%
Veeva Systems
May 29, 2025
Maintains: Overweight
Price Target: $285 → $300
Current: $281.66
Upside: +6.51%
Teladoc Health
May 8, 2025
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $6.96
Upside: +15.03%
GoodRx Holdings
Apr 29, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $3.62
Upside: +93.64%
HealthEquity
Feb 26, 2025
Maintains: Overweight
Price Target: $110 → $125
Current: $91.05
Upside: +37.29%
Health Catalyst
Jan 21, 2025
Maintains: Overweight
Price Target: $13 → $10
Current: $3.74
Upside: +167.38%